Literature DB >> 15478462

Hypothetical structure of human serum amyloid A protein.

Fred J Stevens1.   

Abstract

The proteins known as serum amyloid A (SAA) play major, but relatively uncharacterized, roles in the acute phase response and are important components of the innate immune system of humans and probably all vertebrates. N-terminal fragments of the inducible isoforms, SAA1 and SAA2, are the major constituents of fibrils formed during secondary or reactive amyloidosis. Little is known about the structure of SAA beyond secondary structure analyses and circular dichroism spectroscopic data indicating significant alpha helix conformation. Analysis of the primary structure of human SAA indicates probable homology to the N-terminal domain of hemocyanins of arthropods and suggests that approximately 80% of the molecule may consist of a helical bundle with the remaining portion of the C-terminus potentially disordered. This model of SAA suggests that proposed binding sites for laminin, fibronectin, and calcium are segregated to one face of the molecule and that the heparin/heparan binding site is found in the putatively disordered region of the protein. It is possible that removal of the N-terminal 76 amino acid fragment by proteolytic cleavage found generates an unstable entity that undergoes a helix to beta strand transition analogous to the fibril process of A-beta and prion peptides.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15478462     DOI: 10.1080/13506120412331272296

Source DB:  PubMed          Journal:  Amyloid        ISSN: 1350-6129            Impact factor:   7.141


  10 in total

1.  Structure of serum amyloid A suggests a mechanism for selective lipoprotein binding and functions: SAA as a hub in macromolecular interaction networks.

Authors:  Nicholas M Frame; Olga Gursky
Journal:  FEBS Lett       Date:  2016-03-06       Impact factor: 4.124

Review 2.  High density lipoprotein structure-function and role in reverse cholesterol transport.

Authors:  Sissel Lund-Katz; Michael C Phillips
Journal:  Subcell Biochem       Date:  2010

3.  Structural Basis for Lipid Binding and Function by an Evolutionarily Conserved Protein, Serum Amyloid A.

Authors:  Nicholas M Frame; Meera Kumanan; Thomas E Wales; Asanga Bandara; Marcus Fändrich; John E Straub; John R Engen; Olga Gursky
Journal:  J Mol Biol       Date:  2020-02-06       Impact factor: 5.469

4.  The lipidation status of acute-phase protein serum amyloid A determines cholesterol mobilization via scavenger receptor class B, type I.

Authors:  Gunther Marsche; Sasa Frank; John G Raynes; Karen F Kozarsky; Wolfgang Sattler; Ernst Malle
Journal:  Biochem J       Date:  2007-02-15       Impact factor: 3.857

Review 5.  Serum amyloid A1: Structure, function and gene polymorphism.

Authors:  Lei Sun; Richard D Ye
Journal:  Gene       Date:  2016-03-03       Impact factor: 3.688

Review 6.  Serum amyloid A: an acute-phase protein involved in tumour pathogenesis.

Authors:  E Malle; S Sodin-Semrl; A Kovacevic
Journal:  Cell Mol Life Sci       Date:  2009-01       Impact factor: 9.261

7.  Binding of plasma proteins to titanium dioxide nanotubes with different diameters.

Authors:  Mukta Kulkarni; Ajda Flašker; Maruša Lokar; Katjuša Mrak-Poljšak; Anca Mazare; Andrej Artenjak; Saša Čučnik; Slavko Kralj; Aljaž Velikonja; Patrik Schmuki; Veronika Kralj-Iglič; Snezna Sodin-Semrl; Aleš Iglič
Journal:  Int J Nanomedicine       Date:  2015-02-18

8.  Fibrils from designed non-amyloid-related synthetic peptides induce AA-amyloidosis during inflammation in an animal model.

Authors:  Per Westermark; Katarzyna Lundmark; Gunilla T Westermark
Journal:  PLoS One       Date:  2009-06-30       Impact factor: 3.240

9.  Serum amyloid A is a retinol binding protein that transports retinol during bacterial infection.

Authors:  Mehabaw G Derebe; Clare M Zlatkov; Sureka Gattu; Kelly A Ruhn; Shipra Vaishnava; Gretchen E Diehl; John B MacMillan; Noelle S Williams; Lora V Hooper
Journal:  Elife       Date:  2014-07-29       Impact factor: 8.140

Review 10.  Serum amyloid A - a review.

Authors:  George H Sack
Journal:  Mol Med       Date:  2018-08-30       Impact factor: 6.354

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.